SEC Form 4 · accession 0002137804-26-000004
Medtronic plc · MDT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kweli Thompson
Officer — EVP & President, Neuroscience
Period of report
Jul 31, 2026
Accepted (ET)
Aug 4, 2026 · 7:59 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001613103
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Jul 31, 2026 | F | 1,739 | $85.39 | D | 28,467 | D | |
| Ordinary SharesF3 | Aug 3, 2026 | A | 6,923 | $0.00 | A | 35,390 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance Share UnitsF4,F5,F6 | — | Aug 3, 2026 | A | 17,306 | A | — | — | Ordinary Shares | 17,306 | 17,306 | D |
| Stock Option (Right to Buy)F7 | $86.68 | Aug 3, 2026 | A | 49,167 | A | — | Aug 3, 2036 | Ordinary Shares | 49,167 | 49,167 | D |
Explanation of responses
- F1Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.
- F2Includes 188 shares acquired through dividend reinvestment since the last report filed by the reporting person.
- F3Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
- F4Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
- F5Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.
- F6The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 17,306 shares will be issued. If maximum performance metrics are achieved, 41,534 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
- F7These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.